May 2016, Vol. 5, No. 4

← Back to Issue

Serving All on the Oncology Care Team

Al B. Benson III, MD, FACP, FASCO

Letter to Our Readers

Dear Colleague,

Serving All on the Oncology Care TeamOver the past decade, we’ve experienced tremendous changes in the way we care for and treat patients with cancer. From research targets to available treatments; from management strategies to the very makeup of the multidisciplinary team. The publishers of Personalized Medicine in Oncology (PMO) recognize that to provide the best care to our patients, it takes a village. As a result, the oncology care team has evolved to include growing roles for physicians, nurses, pathologists, nurse and patient navigators, and, of course, the patient. To best support the efforts of those on the team, our publishers have multiple journals designed for members of the care team. Most recently, the publishers of PMO and the Journal of Oncology Navigation & Survivorship launched a patient magazine called CONQUER: the patient voice. This magazine was created in the hope of providing valuable information to patients, family, friends, and caregivers. We are delighted that CONQUER has celebrated its 1-year anniversary and hope it has proved valuable to your patients. We encourage you to pass the word along to your patients that this resource is available to them by visiting www.conquer-magazine.com. They can also complete the postcard on the cover and mail it to begin receiving future issues to their home address.

Within this issue of PMO, we feature an interview with the Editor in Chief of our sister publication, Journal of Oncology Navigation & Survivorship, Lillie D. Shockney, RN, BS, MAS, Johns Hopkins University, about the incorporation of the oncology nurse navigator into our cancer care teams.

We also feature an article from Drs Najjar and Kirkwood about the state of personalized medicine in melanoma as well as an insightful summary of research on perspectives of personalized medicine from Drs Miller, Garfield, and Woodman.

As always, we are proud to present The Last Word from Dr Edward Abrahams of the Personalized Medicine Coalition. In this installment, Dr Abrahams writes about Vice President Biden’s Moonshot initiative.

Thank you for your loyal readership. We value your participation; please contact us with your intriguing case studies, article ideas, and feedback at editorial@the-lynx-group.com.

Sincerely,

Al B. Benson III, MD, FACP, FASCO
Coeditor in Chief
Personalized Medicine in Oncology

Please visit www.conquer-magazine.com today.

The Last Word - May 11, 2016

Biden’s “Moonshot”

Vice President Joe Biden closed the 2016 American Association for Cancer Research annual meeting in New Orleans by telling the audience what he had learned since his son, Beau, had been diagnosed with glioblastoma some 5 years ago. To cure cancer, he said, or in his words, “to make a [ Read More ]

Melanoma - May 11, 2016

Melanoma: A New Frontier in Personalized Medicine

The standard of care for patients with advanced-stage melanoma has shifted from empiric treatment with chemotherapy that has low response rates to targeted therapy with response rates that are substantially higher, and immunotherapy, which has shown the most durable disease control. Chemotherapy is not intrinsically able to differentiate between tumor [ Read More ]